Skip to main content

Westmount Partners, LLC

Position in LLY — ELI LILLY & Co

CIK 2051491 LOS ANGELES, CA

Position in LLY

as of Jun 30, 2026 · filed Jul 7, 2026
Position Value
$2,745,495
+$623,586 QoQ
Shares Held
2,289
-0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
#2,208
of 4,605 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 56% Shared 0% None 44%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Jun 30, 2026
CallValue
$119,943
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Westmount Partners, LLC holds $10,104,775 across 9 Drug Manufacturers - General names. LLY ranks #1 (27.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page
2,289 $2,745,495

All Filings in LLY

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $119,943 100
2026-06-30 $2,745,495 2,289
2026-03-31 $2,121,909 2,307
2025-12-31 $2,211,691 2,058
2025-09-30 $1,564,150 2,050
2025-06-30 $1,835,793 2,355
2025-03-31 $1,770,751 2,144
2024-12-31 $1,597,268 2,069
2024-09-30 $2,070,441 2,337
2024-06-30 $1,009,498 1,115
2024-03-31 $830,083 1,067
2023-12-31 $595,744 1,022
2023-09-30 $491,473 915
2023-06-30 $374,246 798
2023-03-31 $280,230 816
2022-12-31 $261,575 715